NCT02186756

A Randomized Controlled Trial to Evaluate the Effectiveness of Electromyography (EMG)-Biofeedback in Patients With Fibromyalgia

Biofeedback in Patients With Fibromyalgia - a Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Ludwig-Maximilians - University of Munich · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether EMG-Biofeedback is effective in the treatment of Fibromyalgia.

Detailed description

The objective of this randomized controlled trial is to evaluate the effectiveness of EMG-biofeedback in patients with Fibromyalgia. The assessors are blinded to the group assignment. There are three time points of assessment: before intervention, at the end of treatment (T1) and 3-months follow-up (T2). Patients are recruited from the waiting list of the Fibromyalgia day hospital program at the University Hospital Munich fulfilling the inclusion criteria. The intervention group is treated with 14 sessions of EMG-biofeedback during eight weeks in addition to usual care. The control group receives usual care only. The main specific aim is to assess the change in fibromyalgia specific health status.

Conditions

• Fibromyalgia

Interventions

Type	Name	Description
OTHER	EMG-Biofeedback and Usual care	Please refer to arm description

Timeline

• Start date: 2005-04-01
• Primary completion: 2006-07-01
• Completion: 2006-07-01
• First posted: 2014-07-10
• Last updated: 2014-07-10